| Name | Dankmeyer Inc |
|---|---|
| Organization Name | Dankmeyer, Inc |
| Location | 403 Purdy St, Ste 203, Easton, Maryland 21601 |
| Type | Prosthetic/Orthotic Supplier |
| Phone | (410) 636-8114 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Glioblastoma is the most common of malign brain tumors in adults, and it currently has no cure. Now a research team led by Dr Claudia Barros, from the Plymouth University Peninsula Schools of Medicine and Dentistry and its Brain Tumour Research-funded Centre of Excellence, has secured funding from the Brain Research Trust, which will help to expose novel molecules and their modes of action responsible for the initiation and growth of the disease.
Cadence Pharmaceuticals, Inc. today announced that its underwriters partially exercised their over-allotment option in connection with its previously announced public offering that priced on November 11, 2010, by purchasing an additional 1,000,000 shares of its common stock at a public offering price of $8.00 per share. Including the over-allotment shares purchased, Cadence sold a total of 12,500,000 shares in the offering, resulting in expected aggregate gross proceeds to the company of $100 million.
Contrary to previous studies, female-to-male transsexuals do not have a higher prevalence of polycystic ovary syndrome (PCOS), though they do have significantly higher androgen levels, according to a new study accepted for publication in the Journal of Clinical Endocrinology & Metabolism (JCEM).
A seminar in this week's issue of THE LANCET discusses the causes, symptoms, and treatments relating to spina bifida, and reinforces an important public-health message for women about to become pregnant
› Verified 5 days ago
| NPI Number | 1811101835 |
| Organization Name | DANKMEYER INC |
| Type | Prosthetic/Orthotic Supplier |
| Address | 403 Purdy Street, Suite 203, Easton, MD 21601 |
| Phone Number | 410-636-8114 |
News Archive
Glioblastoma is the most common of malign brain tumors in adults, and it currently has no cure. Now a research team led by Dr Claudia Barros, from the Plymouth University Peninsula Schools of Medicine and Dentistry and its Brain Tumour Research-funded Centre of Excellence, has secured funding from the Brain Research Trust, which will help to expose novel molecules and their modes of action responsible for the initiation and growth of the disease.
Cadence Pharmaceuticals, Inc. today announced that its underwriters partially exercised their over-allotment option in connection with its previously announced public offering that priced on November 11, 2010, by purchasing an additional 1,000,000 shares of its common stock at a public offering price of $8.00 per share. Including the over-allotment shares purchased, Cadence sold a total of 12,500,000 shares in the offering, resulting in expected aggregate gross proceeds to the company of $100 million.
Contrary to previous studies, female-to-male transsexuals do not have a higher prevalence of polycystic ovary syndrome (PCOS), though they do have significantly higher androgen levels, according to a new study accepted for publication in the Journal of Clinical Endocrinology & Metabolism (JCEM).
A seminar in this week's issue of THE LANCET discusses the causes, symptoms, and treatments relating to spina bifida, and reinforces an important public-health message for women about to become pregnant
› Verified 5 days ago
News Archive
Glioblastoma is the most common of malign brain tumors in adults, and it currently has no cure. Now a research team led by Dr Claudia Barros, from the Plymouth University Peninsula Schools of Medicine and Dentistry and its Brain Tumour Research-funded Centre of Excellence, has secured funding from the Brain Research Trust, which will help to expose novel molecules and their modes of action responsible for the initiation and growth of the disease.
Cadence Pharmaceuticals, Inc. today announced that its underwriters partially exercised their over-allotment option in connection with its previously announced public offering that priced on November 11, 2010, by purchasing an additional 1,000,000 shares of its common stock at a public offering price of $8.00 per share. Including the over-allotment shares purchased, Cadence sold a total of 12,500,000 shares in the offering, resulting in expected aggregate gross proceeds to the company of $100 million.
Contrary to previous studies, female-to-male transsexuals do not have a higher prevalence of polycystic ovary syndrome (PCOS), though they do have significantly higher androgen levels, according to a new study accepted for publication in the Journal of Clinical Endocrinology & Metabolism (JCEM).
A seminar in this week's issue of THE LANCET discusses the causes, symptoms, and treatments relating to spina bifida, and reinforces an important public-health message for women about to become pregnant
› Verified 5 days ago
Rite Aid Pharmacy 03758 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 101 Marlboro Ave, Easton, Maryland 21601 Phone: (410) 822-0500 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 29523 Canvasback Dr, Easton, Maryland 21601 Phone: (410) 770-8789 | |
Cvs Pharmacy #02531 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8290 Ocean Gtwy, Easton, Maryland 21601 Phone: (410) 763-6501 | |
Cvs Pharmacy #17378 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 28539 Marlboro Ave, Easton, Maryland 21601 Phone: (410) 770-6181 | |
Hill's Drug Store Inc Type: Pharmacy Location: 503 Cynwood Dr, Easton, Maryland 21601 Phone: (410) 763-8966 |